[Abstract Only] Randomized trial: Continuing vs. tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial – The Lancet

Commentary: Reducing corticosteroid use in rheumatoid arthritis – Charité – Universitätsmedizin Berlin

Commentary on Twitter

NEW Research—Continuing vs tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial https://t.co/gtR7xmZlGS pic.twitter.com/UO1EqItU66

— The Lancet (@TheLancet) July 28, 2020